Denali Therapeutics Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
DNLI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
161 Oyster Point Blvd., South San Francisco, CA

Insiders trading volume in the past year

Denali Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert Nelsen Director $178M Jun 2, 2021
Baker Bros. Advisors Lp Director $56.2M Jun 3, 2025
Ryan J. Watts President and CEO, Director $37.4M -$9.29M -19.9% Sep 3, 2025
Marc Tessier-Lavigne Director $34.9M Jun 3, 2025
E. Krognes Director $13.4M -$677K -4.82% Jun 3, 2025
Alexander O. Schuth COFO and Secretary $11.4M -$813K -6.64% Aug 12, 2025
Jay T. Flatley Director $5.8M Jun 3, 2025
Carole Ho Chief Medical Officer $3.56M -$360K -9.18% Aug 12, 2025
Vicki L. Sato Director $2.26M -$178K -7.32% Jan 2, 2025
David P. Schenkein Director $764K -$1.93M -71.7% Jun 3, 2025
Douglas G. Cole Director $489K Jun 1, 2023
Peter S. Klein Director $453K Jun 3, 2025
Jennifer Cook Director $429K Jun 3, 2025
Nancy Thornberry Director $406K Jun 3, 2025
Erik Harris Director $348K May 31, 2024
Julian Baker Director Jun 3, 2025

Recent Insider Transactions by Companies or Individuals for Denali Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.